1
Return

Inhibitory effect of gut microbiota-fermented trisaccharide GuFGa (Glc-Fuc-Gal) on Campylobacter jejuni: insights from transcriptomic and metabolomic analyses

delete2026-07-06
delete0
PRE
AI
X
Xinmiao Ren
S
Shuang Li
C
Changyun Wang
F
Francesco Secundo
N
Ningyang Li
M
Mengshi Xiao
M
Min Yang
R
Rong Li
Q
Qing Kong
H
Han Sun
X
Xiaodan Fu *
H
Haijin Mou *
DOI:10.1007/s42995-026-00394-1delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Fucose-rich carbohydrates, such as 2'-fucosyllactose and fucoidan, are recognized as anti-infective components that protect the host from pathogens. In this study, the response of the common enteric pathogen Campylobacter jejuni to a specific fucose-containing trisaccharide (GuFGa, β-D-Glcp-(1 → 4)-[β-D-Galp-(1 → 3)]-α-ʟ-Fucp) fermented with human fecal microbiota was investigated using metabolomic and transcriptomic analyses. The protective effect of GuFGa-derived microbial metabolites against C. jejuni was assessed in vitro using a cell-based model. No directly inhibitory effect of GuFGa was observed with the growth of C. jejuni during single-strain cultivation. However, the supernatant of GuFGa fermented with human fecal microbiota (F-GuFGa) reduced the relative abundance of C. jejuni by tenfold within the microbial community. Transcriptome data showed that 128 differentially expressed genes of C. jejuni induced by F-GuFGa treatment were mainly enriched in oxidative phosphorylation and bacterial secretion systems (type IV). Fecal fermentation of GuFGa altered 452 differentially abundant metabolites, which were mainly enriched in phenylalanine and tryptophan metabolism. Correlation analysis indicated that the expression of type IV secretion system genes was significantly negatively correlated with the abundance of phenylacetic acid (PAA) and D-3-phenyllactic acid (D-PLA) (P < 0.05). Adhesion of C. jejuni to Caco-2 cells was reduced by treatment with F-GuFGa, PAA and D-PLA, with the highest inhibition rate observed for F-GuFGa (44.4%), followed by D-PLA (33.3%). This study provides a new perspective for developing GuFGa and similarly fucose-rich oligosaccharides as innovative dietary interventions to inhibit bacterial infections and improve gut health.
Keywords:
Fucose-rich oligosaccharide
Gut microbiota
Campylobacter jejuni
Aromatic acid
In vitro fermentation
Caco-2 cell

Journal

M
Marine Life Science & Technology
IF:
5.3
Papers:
70
Citations:
0

Organization

S
School of Medicine and Pharmacy
Scholars:
116
Papers: 28
Citations: 0
C
College of Life Science
Scholars:
1.1K
Papers: 349
Citations: 1
C
College of Food Science and Engineering
Scholars:
757
Papers: 192
Citations: 1
Q
Qingdao Women and Children's Hospital
Scholars:
58
Papers: 37
Citations: 481
S
School of Resources and Environment
Scholars:
55
Papers: 21
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers